Ermium Therapeutics is Drug Discovery in France that focus on chemokine receptor business. Founded in 2019. They cover business area such as developer, orally available drug therapy, autoimmune inflammatory disease, development, g protein-couple receptor, GPCR, chemokine receptor, inflammation, action, physician, plasmacytoid dendritic cell, pdc.
2019
( 5 years old in 2024 )
Chemokine Receptor
-
16 Boulevard Saint Germain
75005 Paris
France
Private
developerorally available drug therapyautoimmune inflammatory diseasedevelopmentg protein-couple receptorGPCRchemokine receptorinflammationactionphysicianplasmacytoid dendritic cellpdc
* We use standard office opening hours in near Ermium Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Ermium Therapeutics is Drug Discovery business from France that founded in 2019 (5 years old in 2024), Ermium Therapeutics business is focusing on Chemokine Receptor.
Ermium Therapeutics headquarter office and corporate office address is located in 16 Boulevard Saint Germain 75005 Paris France.
Ermium Therapeutics was founded in France.
In 2024, Ermium Therapeutics is currently focus on chemokine receptor sector.
Above is snippet of Google Trends for "chemokine receptor" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Ermium Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
